Drug therapy: Treatment of pulmonary arterial hypertension

被引:1285
作者
Humbert, M [1 ]
Sitbon, O [1 ]
Simonneau, G [1 ]
机构
[1] Univ Paris 11, Assistance Publ Hop Paris, Hop Antoine Beclere,Ctr Malad Vasc Pulm, Serv Pneumol & Reanimat Resp,Unite Propre Rech En, Clamart, France
关键词
D O I
10.1056/NEJMra040291
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1425 / 1436
页数:12
相关论文
共 97 条
  • [1] Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension
    Aguilar, RV
    Farber, HW
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (05) : 1846 - 1850
  • [2] Characterization of high-altitude pulmonary hypertension in the Kyrgyz: Association with angiotensin-converting enzyme genotype
    Aldashev, AA
    Sarybaev, AS
    Sydykov, AS
    Kalmyrzaev, BB
    Kim, EV
    Mamanova, LB
    Maripov, R
    Kojonazarov, BK
    Mirrakhimov, MM
    Wilkins, MR
    Morrell, NW
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (10) : 1396 - 1402
  • [3] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial
    Badesch, DB
    Tapson, VF
    McGoon, MD
    Brundage, BH
    Rubin, LJ
    Wigley, FM
    Rich, S
    Barst, RJ
    Barrett, PS
    Kral, KM
    Jöbsis, MM
    Loyd, JE
    Murali, S
    Frost, A
    Girgis, R
    Bourge, RC
    Ralph, DD
    Elliott, CG
    Hill, NS
    Langleben, D
    Schilz, RJ
    McLaughlin, VV
    Robbins, IM
    Groves, BM
    Shapiro, S
    Medsger, TA
    Gaine, SP
    Horn, E
    Decker, JC
    Knobil, K
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) : 425 - +
  • [4] Sitaxsentan therapy for pulmonary arterial hypertension
    Barst, RJ
    Langleben, D
    Frost, A
    Horn, EM
    Oudiz, R
    Shapiro, S
    McLaughlin, V
    Hill, N
    Tapson, VF
    Robbins, IM
    Zwicke, D
    Duncan, B
    Dixon, RAF
    Frumkin, LR
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (04) : 441 - 447
  • [5] Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension - Open-label pilot study
    Barst, RJ
    Rich, S
    Widlitz, A
    Horn, EM
    McLaughlin, V
    McFarlin, J
    [J]. CHEST, 2002, 121 (06) : 1860 - 1868
  • [6] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
    Barst, RJ
    Rubin, LJ
    Long, WA
    McGoon, MD
    Rich, S
    Badesch, DB
    Groves, BM
    Tapson, VF
    Bourge, RC
    Brundage, BH
    Koerner, SK
    Langleben, D
    Keller, CA
    Murali, S
    Uretsky, BF
    Clayton, LM
    Jobsis, MM
    Blackburn, SD
    Shortino, D
    Crow, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) : 296 - 301
  • [7] Beraprost therapy for pulmonary arterial hypertension
    Barst, RJ
    McGoon, M
    McLaughlin, V
    Tapson, V
    Oudiz, R
    Shapiro, S
    Robbins, IM
    Channick, R
    Badesch, D
    Rayburn, BK
    Flinchbaugh, R
    Sigman, J
    Arneson, C
    Jeffs, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) : 2119 - 2125
  • [8] Endothelin antagonists
    Benigni, A
    Remuzzi, G
    [J]. LANCET, 1999, 353 (9147) : 133 - 138
  • [9] Immediate and long-term hemodynamic and clinical effects of Sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy
    Bhatia, S
    Frantz, RP
    Severson, CJ
    Durst, LA
    McGoon, MD
    [J]. MAYO CLINIC PROCEEDINGS, 2003, 78 (10) : 1207 - 1213
  • [10] PRIMARY PULMONARY-HYPERTENSION - A HISTOPATHOLOGIC STUDY OF 80 CASES
    BJORNSSON, J
    EDWARDS, WD
    [J]. MAYO CLINIC PROCEEDINGS, 1985, 60 (01) : 16 - 25